Generation Bio (GBIO) EBIT (2022 - 2025)
Historic EBIT for Generation Bio (GBIO) over the last 4 years, with Q3 2025 value amounting to -$6.7 million.
- Generation Bio's EBIT rose 6249.16% to -$6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$69.8 million, marking a year-over-year increase of 5561.6%. This contributed to the annual value of -$142.4 million for FY2024, which is 276.19% down from last year.
- Per Generation Bio's latest filing, its EBIT stood at -$6.7 million for Q3 2025, which was up 6249.16% from -$22.9 million recorded in Q2 2025.
- Generation Bio's EBIT's 5-year high stood at -$6.7 million during Q3 2025, with a 5-year trough of -$77.6 million in Q1 2024.
- Over the past 4 years, Generation Bio's median EBIT value was -$32.0 million (recorded in 2022), while the average stood at -$30.9 million.
- As far as peak fluctuations go, Generation Bio's EBIT tumbled by 12266.39% in 2024, and later surged by 7860.99% in 2025.
- Over the past 4 years, Generation Bio's EBIT (Quarter) stood at -$34.7 million in 2022, then decreased by 10.76% to -$38.4 million in 2023, then soared by 38.67% to -$23.6 million in 2024, then skyrocketed by 71.53% to -$6.7 million in 2025.
- Its EBIT stands at -$6.7 million for Q3 2025, versus -$22.9 million for Q2 2025 and -$16.6 million for Q1 2025.